Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.#ImmuneResetAI researchClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

Effects of B Cell Depletion Therapy on EBV-specific T-cells in Multiple Sclerosis

In an observational study of 183 participants, including 54 with MS receiving B cell depletion therapy (BCDT), results showed that BCDT is associated with lower frequencies of EBV-specific T-cells while maintaining T-cell functionality. Notably, patients treated with ofatumumab had higher EBV-specific CD8⁺ T-cell frequencies compared to those treated with ocrelizumab.

What this does not proveThe specific effects of BCDT on EBV-specific immunity are not fully understood, especially compared to untreated MS patients and healthy controls.
#ImmuneReset
View abstract on PubMedPMID 42806375AI summary of a published abstract. Not medical advice.